Skip to main content

Postdoc - Epigenetics and Molecular Carcinogenesis

Employer
University of Texas MD Anderson Cancer Center
Location
Houston, Texas
Salary
Competitive
Closing date
Aug 2, 2024

View more

Discipline
Health Sciences
Organization Type
Healthcare/Hospital

Job Details

The University of Texas MD Anderson Cancer Center invites applications for postdoctoral fellowships starting immediately in epigenetic biology, DNA methylation, transcription factors and functional somatic mutations, using state-of-the-art tools of biochemical, enzymology and structural biology.

The postdoctoral research will be performed in a highly interdisciplinary and collaborative environment with world-class experts and advanced technologies and facilities, which provide unique and ideal career development opportunities for postdocs. Successful candidates will be supervised by Dr. Xiaodong Cheng, a senior faculty member and recognized leader in epigenetics, who have successfully trained ~40 postdocs. Recent representative publications on transcription factors HIC2 (Nature Genetics, 2022), ZNF410 (Mol. Cell, 2021 and NAR 2023), ZBTB7A (Cell Reports, 2021 and JBC 2023), DNMT1 inhibition (Structure, 2022 and Nature Cancer, 2021) and inhibition of C. difficile specific DNA adenine methyltransferase CamA (Nature Communications, 2021 and JMC 2023). For more information, please visit LINK TO INFO

The trainee will learn how to design and execute quantitative experiments in a safe, supportive, and inclusive environment, with the highest standard of ethical, responsible, and rigorous scientific research. The trainee will participate in professional development activities and in collaborative projects and present findings at a prestigious national/international conference, to prepare for the chosen career.

LEARNING OBJECTIVES
The trainee will learn how to design and execute quantitative experiments in a safe, supportive, and inclusive environment, with the highest standard of ethical, responsible, and rigorous scientific research. The trainee will participate in professional development activities and in collaborative projects and present findings at a prestigious national/international conference, to prepare for the chosen career.

ELIGIBILITY REQUIREMENTS
Applicants should have a recent Ph.D. degree (or equivalent) in molecular biology, cancer biology, genetics/epigenetics, or relevant fields. We are interested in passionate and self-motivated candidates who ask fundamentally important questions and are bold in taking innovative approaches.

POSITION INFORMATION
MD Anderson follows the NIH stipend levels as outlined by the Kirchstein - NRSA . This full-time trainee position will provide a salary between $56,484 to $68,604, dependent upon the years of postgraduate experience.

MD Anderson offers compensated trainees:
- Paid medical benefits (zero premium) starting on first day for trainees who work 30 or more hours per week
- Group Dental, Vision, Life, AD&D and Disability coverage
- Paid Education Vacation and Sick Leave
- Paid institutional holidays, wellness leave, childcare leave and other paid leave programs
- Teachers Retirement System defined-benefit pension plan and two voluntary retirement plans
- Employer paid life, AD&D and an illness-related reduced salary pay program
- Health Savings Account and Dependent Care Reimbursement flexible spending accounts
- Fertility benefits
- State of Texas longevity pay
- Extensive wellness, fitness, employee health programs and employee resource groups

Company

The University of Texas MD Anderson Cancer Center in Houston is one of the world's most respected centers focused on cancer patient care, research, education and prevention. It was named the nation's No. 1 hospital for cancer care in U.S. News & World Report's 2023 rankings. It is one of the nation's original three comprehensive cancer centers designated by the National Cancer Institute.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert